The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
C1 Esterase Inhibitor-Global Market Insights and Sales Trends 2024
Synopsis
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
The global C1 Esterase Inhibitor market size is expected to reach US$ 194 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of C1 Esterase Inhibitor in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling C1 Esterase Inhibitor market. Human, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for C1 Esterase Inhibitor, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global C1 Esterase Inhibitor market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global C1 Esterase Inhibitor market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, C1 Esterase Inhibitor sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of C1 Esterase Inhibitor covered in this report include CSL Behring, Takeda and Pharming Intellectual, etc.
The global C1 Esterase Inhibitor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Takeda
Pharming Intellectual
Global C1 Esterase Inhibitor market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global C1 Esterase Inhibitor market, Segment by Type:
Human
Recombinant
Global C1 Esterase Inhibitor market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of C1 Esterase Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
The global C1 Esterase Inhibitor market size is expected to reach US$ 194 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of C1 Esterase Inhibitor in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling C1 Esterase Inhibitor market. Human, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for C1 Esterase Inhibitor, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global C1 Esterase Inhibitor market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global C1 Esterase Inhibitor market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, C1 Esterase Inhibitor sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of C1 Esterase Inhibitor covered in this report include CSL Behring, Takeda and Pharming Intellectual, etc.
The global C1 Esterase Inhibitor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CSL Behring
Takeda
Pharming Intellectual
Global C1 Esterase Inhibitor market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global C1 Esterase Inhibitor market, Segment by Type:
Human
Recombinant
Global C1 Esterase Inhibitor market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of C1 Esterase Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 C1 Esterase Inhibitor Market Overview
1.1 C1 Esterase Inhibitor Product Overview
1.2 C1 Esterase Inhibitor Market Segment by Type
1.2.1 Human
1.2.2 Recombinant
1.3 Global C1 Esterase Inhibitor Market Size by Type
1.3.1 Global C1 Esterase Inhibitor Market Size Overview by Type (2018-2029)
1.3.2 Global C1 Esterase Inhibitor Historic Market Size Review by Type (2018-2023)
1.3.3 Global C1 Esterase Inhibitor Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America C1 Esterase Inhibitor Sales Breakdown by Type (2018-2023)
1.4.2 Europe C1 Esterase Inhibitor Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific C1 Esterase Inhibitor Sales Breakdown by Type (2018-2023)
1.4.4 Latin America C1 Esterase Inhibitor Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa C1 Esterase Inhibitor Sales Breakdown by Type (2018-2023)
2 Global C1 Esterase Inhibitor Market Competition by Company
2.1 Global Top Players by C1 Esterase Inhibitor Sales (2018-2023)
2.2 Global Top Players by C1 Esterase Inhibitor Revenue (2018-2023)
2.3 Global Top Players by C1 Esterase Inhibitor Price (2018-2023)
2.4 Global Top Manufacturers C1 Esterase Inhibitor Manufacturing Base Distribution, Sales Area, Product Type
2.5 C1 Esterase Inhibitor Market Competitive Situation and Trends
2.5.1 C1 Esterase Inhibitor Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by C1 Esterase Inhibitor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2022)
2.7 Date of Key Manufacturers Enter into C1 Esterase Inhibitor Market
2.8 Key Manufacturers C1 Esterase Inhibitor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 C1 Esterase Inhibitor Status and Outlook by Region
3.1 Global C1 Esterase Inhibitor Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global C1 Esterase Inhibitor Historic Market Size by Region
3.2.1 Global C1 Esterase Inhibitor Sales in Volume by Region (2018-2023)
3.2.2 Global C1 Esterase Inhibitor Sales in Value by Region (2018-2023)
3.2.3 Global C1 Esterase Inhibitor Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global C1 Esterase Inhibitor Forecasted Market Size by Region
3.3.1 Global C1 Esterase Inhibitor Sales in Volume by Region (2024-2029)
3.3.2 Global C1 Esterase Inhibitor Sales in Value by Region (2024-2029)
3.3.3 Global C1 Esterase Inhibitor Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global C1 Esterase Inhibitor by Application
4.1 C1 Esterase Inhibitor Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global C1 Esterase Inhibitor Market Size by Application
4.2.1 Global C1 Esterase Inhibitor Market Size Overview by Application (2018-2029)
4.2.2 Global C1 Esterase Inhibitor Historic Market Size Review by Application (2018-2023)
4.2.3 Global C1 Esterase Inhibitor Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America C1 Esterase Inhibitor Sales Breakdown by Application (2018-2023)
4.3.2 Europe C1 Esterase Inhibitor Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific C1 Esterase Inhibitor Sales Breakdown by Application (2018-2023)
4.3.4 Latin America C1 Esterase Inhibitor Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa C1 Esterase Inhibitor Sales Breakdown by Application (2018-2023)
5 North America C1 Esterase Inhibitor by Country
5.1 North America C1 Esterase Inhibitor Historic Market Size by Country
5.1.1 North America C1 Esterase Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America C1 Esterase Inhibitor Sales in Volume by Country (2018-2023)
5.1.3 North America C1 Esterase Inhibitor Sales in Value by Country (2018-2023)
5.2 North America C1 Esterase Inhibitor Forecasted Market Size by Country
5.2.1 North America C1 Esterase Inhibitor Sales in Volume by Country (2024-2029)
5.2.2 North America C1 Esterase Inhibitor Sales in Value by Country (2024-2029)
6 Europe C1 Esterase Inhibitor by Country
6.1 Europe C1 Esterase Inhibitor Historic Market Size by Country
6.1.1 Europe C1 Esterase Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe C1 Esterase Inhibitor Sales in Volume by Country (2018-2023)
6.1.3 Europe C1 Esterase Inhibitor Sales in Value by Country (2018-2023)
6.2 Europe C1 Esterase Inhibitor Forecasted Market Size by Country
6.2.1 Europe C1 Esterase Inhibitor Sales in Volume by Country (2024-2029)
6.2.2 Europe C1 Esterase Inhibitor Sales in Value by Country (2024-2029)
7 Asia-Pacific C1 Esterase Inhibitor by Region
7.1 Asia-Pacific C1 Esterase Inhibitor Historic Market Size by Region
7.1.1 Asia-Pacific C1 Esterase Inhibitor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific C1 Esterase Inhibitor Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific C1 Esterase Inhibitor Sales in Value by Region (2018-2023)
7.2 Asia-Pacific C1 Esterase Inhibitor Forecasted Market Size by Region
7.2.1 Asia-Pacific C1 Esterase Inhibitor Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific C1 Esterase Inhibitor Sales in Value by Region (2024-2029)
8 Latin America C1 Esterase Inhibitor by Country
8.1 Latin America C1 Esterase Inhibitor Historic Market Size by Country
8.1.1 Latin America C1 Esterase Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America C1 Esterase Inhibitor Sales in Volume by Country (2018-2023)
8.1.3 Latin America C1 Esterase Inhibitor Sales in Value by Country (2018-2023)
8.2 Latin America C1 Esterase Inhibitor Forecasted Market Size by Country
8.2.1 Latin America C1 Esterase Inhibitor Sales in Volume by Country (2024-2029)
8.2.2 Latin America C1 Esterase Inhibitor Sales in Value by Country (2024-2029)
9 Middle East and Africa C1 Esterase Inhibitor by Country
9.1 Middle East and Africa C1 Esterase Inhibitor Historic Market Size by Country
9.1.1 Middle East and Africa C1 Esterase Inhibitor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa C1 Esterase Inhibitor Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa C1 Esterase Inhibitor Sales in Value by Country (2018-2023)
9.2 Middle East and Africa C1 Esterase Inhibitor Forecasted Market Size by Country
9.2.1 Middle East and Africa C1 Esterase Inhibitor Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa C1 Esterase Inhibitor Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Information
10.1.2 CSL Behring Introduction and Business Overview
10.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2018-2023)
10.1.4 CSL Behring C1 Esterase Inhibitor Products Offered
10.1.5 CSL Behring Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Takeda C1 Esterase Inhibitor Products Offered
10.2.5 Takeda Recent Development
10.3 Pharming Intellectual
10.3.1 Pharming Intellectual Company Information
10.3.2 Pharming Intellectual Introduction and Business Overview
10.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pharming Intellectual C1 Esterase Inhibitor Products Offered
10.3.5 Pharming Intellectual Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 C1 Esterase Inhibitor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 C1 Esterase Inhibitor Industrial Chain Analysis
11.4 C1 Esterase Inhibitor Market Dynamics
11.4.1 C1 Esterase Inhibitor Industry Trends
11.4.2 C1 Esterase Inhibitor Market Drivers
11.4.3 C1 Esterase Inhibitor Market Challenges
11.4.4 C1 Esterase Inhibitor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 C1 Esterase Inhibitor Distributors
12.3 C1 Esterase Inhibitor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
